In vitro diagnostics specialists today have to design systems capable of carrying out increasingly complex tests while making the results easier to interpret. HORIBA Medical has risen to the challenge by considerably intensifying its research efforts. The company aims to invest over 10% of its sales in R&D in the medium term.
Many new concepts, that are unique, have been introduced in the field of in vitro diagnostics, including the most compact system on the market (Micros designed by HORIBA Medical).
Over 40 “key” patent families have been lodged worldwide, covering all the technologies included in our testing systems.

Indicadores chave

  • Mais de 880 empregados
  • 3 unidades de produção no mundo 
(Montpellier, Kyoto, São Paulo)
  • Mais de 8 % das receitas alocadas para as pesquisas